	Visualized Clinical-Radiomics Model Based on Non-Contrast Computed Tomography for Predicting Efficacy of Surufatinib in Hepatic Metastases of Neuroendocrine Neoplasms. Cancer Med Feng M, Zhao M, Duan X, Hou J, Wang Q, Yin F. PMID: 42120948 [PubMed - indexed for MEDLINE]
	Impact of breast cancer characteristics on the development and time to liver metastases: population-based study. BJS Open Sundén M, Lindqvist E, Wahlqvist E, Hansson E, Wadsten C, Andersson A, Sund M, Hemmingsson O. PMID: 42119146 [PubMed - indexed for MEDLINE]
	Sleeve Resection of the Right Upper Lobe for Tracheobronchial Metastasis of Hepatocellular Carcinoma With Superior Vena Cava Involvement: A Case Report and Literature Review. Am J Case Rep Cao P, Wang Y, Wang Q, Cai W, Zhang R, Li Z, Geng J. PMID: 42118709 [PubMed - indexed for MEDLINE]
	CT Radiomics-based Machine Learning to Identify Intratumoral Fibrosis and Underlying Angiogenesis in Hepatocellular Carcinoma. Radiology Wang TC, Wei N, Bao Y, Li JX, Zhou P, Sun Y, Wang LZ, Cai WW, Chang DH, Xiao YD. PMID: 42117996 [PubMed - indexed for MEDLINE]
	Proposal for Modified Alpha Fetoprotein Use in Hepatocellular Carcinoma Surveillance: Analysis of the 2018-2020 National Cancer Screening Program. J Korean Med Sci Yu S, Kim S, Kim H, Lee HR, Choi J. PMID: 42117149 [PubMed - indexed for MEDLINE]
	Electronic nose versus gas chromatography - mass spectrometry for diagnostic discrimination of advanced hepatocellular carcinoma by volatolomic analysis. BMC Gastroenterol Mahmoud MS, Mshaly MS, Abdel-Reheim HN, Shawki MM, Meshref RA, Mohamed EI. PMID: 42115981 [PubMed - indexed for MEDLINE]
	Chronic HBV infection, stemness pathways, and compromised immune surveillance in HCC development. Allergol Immunopathol (Madr) Razaghi N, Kariminik A, Ranjbar M, Bahaaldin-Beygi M. PMID: 42115809 [PubMed - indexed for MEDLINE]
	Electronic symptom monitoring of patient-reported outcomes among patients with hepatocellular carcinoma during immunotherapy (PRIME-HCC): protocol for a randomised controlled trial. BMJ Open Xia Y, Wei X, Wang Y, Shi Z, He P. PMID: 42114858 [PubMed - indexed for MEDLINE]
	Hepatitis B virus infection and outcomes of TACE plus lenvatinib and PD-1 inhibitor therapy in unresectable hepatocellular carcinoma: a real-world propensity score-matched study. Front Immunol Su Y, Liang Y, Zhong D, Chen Y, Ma S, Wang M, Yang Q, Yan H, Huang X. PMID: 42112392 [PubMed - indexed for MEDLINE]
	The SAGES scoring model leads to personalized treatment via the combination of TACE, TKIs and ICIs for unresectable hepatocellular carcinoma. Front Immunol Lin H, Wang X, Zhong J, Peng N, Liu S, Zeng F, Li W, Su Z, Ou J, Wu P, Yao H, Li S. PMID: 42112317 [PubMed - indexed for MEDLINE]
	Burden of hepatitis B virus-associated liver cancer in Asia: findings from the global burden of disease study. Front Public Health Yang XJ, Yang XQ, Mo XY, Zuo J, Fan YC. PMID: 42110297 [PubMed - indexed for MEDLINE]
	NF-ÎºB Signaling Pathway Activation in Aflatoxin B1-Induced Hepatocellular Toxicity: Molecular Crosstalk With Oxidative Stress and IÎºB Degradation. J Biochem Mol Toxicol Hosawi S. PMID: 42108774 [PubMed - indexed for MEDLINE]
	Infection-Associated Microecology and Hepatocellular Carcinoma. Methods Mol Biol Song Q. PMID: 42108298 [PubMed - indexed for MEDLINE]
	A Case of Pernicious Anemia Induced by Atezolizumab in Hepatocellular Carcinoma and Renal Cell Carcinoma. Am J Case Rep Sugimoto T, Kanemori G, Kanehira H, Kitao A, Nagatani Y. PMID: 42106905 [PubMed - indexed for MEDLINE]
	Development of an innovative nanopolymer-lncRNA-SRHC complex as therapeutic modalities for targeted hepatocellular carcinoma therapy. Sci Rep Elkramani N, Elzallat M, Mohammed DM, AbdelLatif A, Aboushousha T, El-Ahwany E. PMID: 42106389 [PubMed - indexed for MEDLINE]
	Microwave Ablation with or without TACE for Unresectable Large Hepatocellular Carcinoma: Impact of Tumor Burden Score on Efficacy. J Gastrointest Cancer Wang Z, Wang Z, Li J, Li L, Wang S, Liu F, Yu J, Liang P, Yu X. PMID: 42105132 [PubMed - indexed for MEDLINE]
	Development of a machine learning-based prognostic prediction model and a web-based tool for pediatric hepatoblastoma: a Surveillance, Epidemiology, and End Results (SEER) database study. Pediatr Surg Int Chen Z, Wei Y, Liu S, Zhang J. PMID: 42105007 [PubMed - indexed for MEDLINE]
	TACE plus lenvatinib and envafolimab for conversion therapy in unresectable HCC: a prospective pilot study. Front Immunol Su Y, Liang Y, Zhong D, Chen Y, Wang M, Yang Q, Yan H, Huang X. PMID: 42099657 [PubMed - indexed for MEDLINE]
	Current progress and emerging trends of car-based immunotherapy for hepatocellular carcinoma: a data-driven atlas from multidatabase integration. Front Immunol Ying H, Pan Y, Zhu X, Xuan Q. PMID: 42099608 [PubMed - indexed for MEDLINE]
	Inflammation in hepatocellular carcinoma progression: a "Single Wick, dual interwoven strands" regulatory framework. Front Immunol Wu C, Dong J, Sui S, Tan X, Zhu N. PMID: 42099598 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 76080

Page 1 of 3804



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy